top of page

Biotech CEO Sisterhood: EpiBone creates bones and cartilage grown from stem cells - Co-Founder and CEO Nina Tandon describes the creative thinking she has used to accelerate its availability

  • blonca9
  • 1 day ago
  • 2 min read

Interviewed by Sisterhood editorial board member Erika Smith, Nina Tandon describes what it has taken to get a startup through the recent difficult times for the biotech sector, including applying for military funding and making the product available in international markets where compassionate use is an option.





Biographies


ree

Dr. Nina Tandon is the CEO and Co-Founder of EpiBone, Inc., a groundbreaking biotech company revolutionizing skeletal reconstruction with AI-designed, 3D-fabricated living bone and cartilage. A 2001 graduate of Cooper Union with a Bachelor of Engineering in Electrical Engineering, she also holds a Ph.D. and postdoc in tissue engineering and stem cells from Columbia University, as well as an Executive MBA in healthcare entrepreneurship. With over 20 years of expertise, Dr. Tandon’s visionary leadership is driving innovation in regenerative medicine, redefining personalized care, and shaping the future of skeletal health.



ree

Erika Smith is life sciences entrepreneur who has combined technical and business expertise with 30-years of industry experience building, investing in, and successfully exiting life-science and technology companies


Previously, she led EpiTET Therapeutics, developing novel oral therapeutics that selectively eliminates pathogenic macrophages, and ReNetX Bio, a venture funded neuro-science company

As an investor, she served as the inaugural director of the $65M Blavatnik Fund at Yale, launched the Johnson & Johnson investment fund in partnership with the Center for Innovative Technology and was a Venture Advisor to Epidarex Ventures, a transatlantic life-science venture firm. These early-stage investments enabled successful exits including medSage (acq: Philips Healthcare), Isoplexis (NASDAQ: ISO), and Biorez ($250M Acq NYSE: CNMD).


She is the Board Chair (ECS) and on the Executive Committee Board of Biotechnology Innovation Organization (BIO) and a recognized thought leader holding numerous awards including: “Industry Superstar”, “Entrepreneur of the Year,” and co-author of playbook “Empowering Women Entrepreneurs” sponsored by JPMorgan Chase; and TEDx speaker. Erika received a bachelor’s degree in Biomedical and Electrical Engineering and a Master of Business Administration (MBA).

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

bottom of page